Clinical Trial Update: Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

View source ↗

Summary

AstraZeneca-sponsored completed trial assessed the prevalence of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis, and ankylo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Osteoarthritis
• Rheumatoid Arthritis

Snippet

Sponsor: AstraZeneca | Conditions: Osteoarthritis (OA), Rheumatoid Arthritis (RA) | Status: COMPLETED